Table 1.
Baseline data.
| Propofol (N = 44) | Ciprofol (N = 90) | Absolute standardized difference | |
|---|---|---|---|
| Age (year) | 34.9 (9.4) | 34.2 (9.1) | 0.076 |
| Body mass index (kg m−2) | 22.1 (2.7) | 21.9 (2.5) | 0.077 |
| History of surgery | |||
| Artificial abortion | 11 (25.0) | 38 (42.2) | 0.370 |
| Caesarean section | 15 (34.1) | 29 (32.2) | 0.040 |
| Intrauterine device implantation | 6 (13.6) | 6 (6.7) | 0.230 |
| History of general anesthesia | 18 (40.9) | 43 (47.8) | 0.139 |
| History of allergy | 4 (9.1) | 15 (16.7) | 0.228 |
| History of diseases | 34 (77.3) | 81 (90.0) | 0.349 |
| Vaginal infection | 15 (34.1) | 23 (25.6) | 0.187 |
| Leiomyoma of uterus | 6 (13.6) | 12 (13.3) | 0.009 |
| Abnormal uterine bleeding | 1 (2.3) | 9 (10.0) | 0.325 |
| Concomitant medications | |||
| Oxytocin | 17 (38.6) | 28 (31.1) | 0.158 |
| Cephalosporin antibiotic | 20 (45.5) | 29 (32.2) | 0.275 |
| Azithromycin | 7 (15.9) | 10 (11.1) | 0.141 |
| Ornidazole/metronidazole | 11 (25.0) | 19 (21.1) | 0.093 |
| Estrogen/progestin | 10 (22.7) | 28 (31.1) | 0.190 |
| Chinese traditional medicine | 15 (34.1) | 35 (38.9) | 0.100 |
| Fosfomycin trometamol | 6 (13.6) | 10 (11.1) | 0.076 |
| Test result of HCG | 0.361 | ||
| Negative | 8 (18.2) | 30 (33.3) | |
| Positive | 32 (72.7) | 56 (62.2) | |
| Not tested | 4 (9.1) | 4 (4.4) | |
| ASA classification | 0.101 | ||
| Class I | 40 (90.9) | 79 (87.8) | |
| Class II | 4 (9.1) | 11 (12.2) | |
| Modified Mallampati score | 0.254 | ||
| I | 36 (81.8) | 64 (71.1) | |
| II | 8 (18.2) | 26 (28.9) | |
Data are mean (standard deviation) or n (%). HCG, human chorionic gonadotropin; ASA, American Society of Anesthesiologists. Absolute standardized differences in bold indicated >0.360 and were considered imbalanced between the two groups.